Clinical Trials Logo
  1. Home
  2. Hip Arthropathy
  3. NCT03977454

Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty

Hip Arthropathy Clinical Trial

Official title:
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty: a Single Center Randomized Controlled Trail (RCT) Study

Clinical Trial Summary

This study will assess if preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) with ropivacaine and glucocorticoids provide more effective analgesia than periarticular injection (PAI) with the same mixture in total hip arthroplasty (THA).

Clinical Trial Description

To support our hypothesis that preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) provides more effective analgesia than periarticular injection (PAI) in total hip arthroplasty (THA), we will look at the following outcomes: Primary outcome: Daily opioid consumption Secondary outcomes: Pain intensity and physical functioning while in the hospital: using pain inventory modified from Brief Pain Inventory and Length of hospital stays. Since both QLB/LFCNB nerve block and PAI techniques are both routinely used as standard of care anesthesia for THA, the study intervention will be the randomization to assign patients to one of these treatment options and assess their response from post-op patient questionnaires and data collection. When results were entered, the detailed description was updated to reflect the outcome measures used in the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03977454
Study type Interventional
Source Yale University
Contact
Status Completed
Phase Phase 2
Start date November 11, 2019
Completion date June 19, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05556759 - Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Not yet recruiting NCT05015517 - ESP Block vs FIB in Patients Undergoing Hip Arthroplasty N/A
Completed NCT05134207 - The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty N/A
Recruiting NCT04438265 - Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
Recruiting NCT04229368 - Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications N/A
Active, not recruiting NCT05142462 - Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Completed NCT06083428 - Erector Spinae vs. PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05396924 - Rectal Temperature Measurement in Detecting Hypothermia During Hip Arthroscopy N/A
Active, not recruiting NCT05524363 - Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
Recruiting NCT06147401 - Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA N/A
Recruiting NCT05397145 - Iliopsoas Plane Block vs PENG Block for Hip Arthroplasty N/A
Completed NCT03981354 - Nutritional Status and Its Modifications After Hip Replacement
Recruiting NCT06257160 - Superiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery N/A
Active, not recruiting NCT04995822 - Post Market Clinical Follow-up of EUROSTEM Femoral Stem
Completed NCT04883788 - The Impact of COVID-19 Pandemic on Hip and Knee Replacement
Not yet recruiting NCT06317870 - Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty N/A
Completed NCT03541798 - Comparison of Three Different Sitting Positions for Performing Combined Spinal-Epidural Anesthesia N/A
Completed NCT04306133 - PENG Block Combined to Wound Infiltration for Hip Replacement N/A
Completed NCT04123873 - Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty Phase 4